IRIS
D'Angelillo, Rolando Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.803
AS - Asia 3.843
EU - Europa 1.700
SA - Sud America 626
AF - Africa 58
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.043
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.717
SG - Singapore 2.338
BR - Brasile 515
CN - Cina 495
RU - Federazione Russa 406
IT - Italia 402
IE - Irlanda 329
HK - Hong Kong 314
VN - Vietnam 267
BD - Bangladesh 141
FR - Francia 129
DE - Germania 91
JP - Giappone 88
GB - Regno Unito 87
SE - Svezia 58
FI - Finlandia 52
IN - India 42
AR - Argentina 38
CA - Canada 33
UA - Ucraina 30
NL - Olanda 26
MX - Messico 25
EC - Ecuador 23
ID - Indonesia 23
ZA - Sudafrica 23
CO - Colombia 19
AT - Austria 18
KR - Corea 18
IQ - Iraq 15
PL - Polonia 13
SA - Arabia Saudita 12
TR - Turchia 12
ES - Italia 11
PY - Paraguay 11
MA - Marocco 10
UZ - Uzbekistan 10
JM - Giamaica 8
MY - Malesia 8
TH - Thailandia 8
KE - Kenya 7
PK - Pakistan 7
RO - Romania 7
UY - Uruguay 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
BE - Belgio 6
AU - Australia 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
IL - Israele 5
LB - Libano 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
EG - Egitto 4
GR - Grecia 4
GT - Guatemala 4
IR - Iran 4
NZ - Nuova Zelanda 4
TW - Taiwan 4
AL - Albania 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
JO - Giordania 3
PE - Perù 3
PH - Filippine 3
BB - Barbados 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
KG - Kirghizistan 2
KW - Kuwait 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
TN - Tunisia 2
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NG - Nigeria 1
RE - Reunion 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.043
Salva come PNG Salva come JPEG
Città #
Singapore 871
Fairfield 539
Woodbridge 529
Wilmington 498
San Jose 478
Houston 450
Dublin 327
Ashburn 315
Hong Kong 304
Medford 239
Beijing 238
Seattle 186
Santa Clara 172
Cambridge 162
The Dalles 157
Council Bluffs 135
Chandler 129
Lawrence 115
Lauterbourg 101
Los Angeles 94
New York 94
Rome 89
Ann Arbor 87
Tokyo 85
Ho Chi Minh City 78
Buffalo 73
Hanoi 73
San Diego 68
São Paulo 47
Helsinki 40
Moscow 33
North Bergen 29
Chicago 28
Frankfurt am Main 28
Redondo Beach 27
Nuremberg 22
Falls Church 21
London 21
Milan 21
Jacksonville 20
Atlanta 19
Johannesburg 15
Phoenix 15
Rio de Janeiro 15
Seoul 14
Belo Horizonte 13
Montreal 13
Denver 12
Jakarta 12
Toronto 12
Brooklyn 11
Dallas 11
Guayaquil 11
Norwalk 11
Orem 11
Chennai 10
Elk Grove Village 9
Hải Dương 9
Lappeenranta 9
Mumbai 9
Naples 9
San Francisco 9
Stockholm 9
Tashkent 9
Brasília 8
Cagliari 8
Curitiba 8
Mexico City 8
Thái Bình 8
Turin 8
Amsterdam 7
Campinas 7
Da Nang 7
Dearborn 7
Haiphong 7
Manchester 7
Miami 7
Munich 7
Nairobi 7
Nanjing 7
Porto Alegre 7
Shanghai 7
São José dos Campos 7
Warsaw 7
Asunción 6
Caxias do Sul 6
Florence 6
Kilburn 6
Montevideo 6
Riyadh 6
Xian 6
Boston 5
Cape Town 5
Hounslow 5
Joinville 5
Juiz de Fora 5
Kingston 5
Kuala Lumpur 5
Mülheim 5
Newark 5
Totale 7.533
Salva come PNG Salva come JPEG
Nome #
Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy 563
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 449
Beams arrangement in non-small cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 417
Whole-breast irradiation: a subgroup analysis of criteria to stratify for prone position treatment 231
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 183
Dynomics: a novel and promising approach for improved breast cancer prognosis prediction 132
Awake breast cancer surgery: strategy in the beginning of COVID-19 emergency 130
Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: a randomized phase II trial (ARTO) 116
In patient dose reconstruction using a cine acquisition for dynamic arc radiation therapy 112
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence 111
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 111
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 111
Pros-IT CNR: an Italian prostate cancer monitoring project 110
Fractionated stereotactic radiosurgery for patients with brain metastases 107
Chemo-radiotherapy in non-small cell lung cancer: the role of gemcitabine 107
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients 105
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients. 104
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 104
Epid cine acquisition mode for in vivo dosimetry in dynamic arc radiation therapy 101
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 101
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 100
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 100
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 99
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 98
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) 97
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system 96
Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview 95
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 94
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: Preliminary assessment of toxicity 93
Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report 92
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 92
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 92
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 92
Radiation-induced pneumonitis in the era of the COVID-19 pandemic: artificial intelligence for differential diagnosis 92
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 91
Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis 91
Chemoradiation for stage III non-small cell lung cancer 89
Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach 88
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 88
Combining Abiraterone and Radiotherapy in Prostate Cancer Patients Who Progressed During Abiraterone Therapy 88
Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document 88
Radiotherapy and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors in Renal Cancer 87
Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy 87
Long-term outcomes of once-daily accelerated partial-breast irradiation with tomotherapy: Results of a phase 2 trial 87
Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiation Therapy and Clinical Oncology (AIRO) 87
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results 86
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: the experience of a single institution with 269 patients (STONE-01) 86
Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery 85
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience. 84
Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients 84
Incidental surgical findings of a phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer 84
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 84
Pulmonary rehabilitation following radical chemo-radiation in locally advanced non surgical NSCLC: Preliminary evidences 83
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy. 82
Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer 82
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 82
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: a prospective analysis of the italian real-world study ABITUDE 82
Postoperative radiotherapy in completely resected, early-stage, non-small-cell lung cancer: reflections and future directions 81
Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii study 81
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 81
GUROPA survey: genito-urinary radiation oncology prescription attitudes 81
transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer 80
The Italian Association of Radiotherapy and Oncology recommendation for breast tumor Recurrence: Grades of recommendation, assessment, development and evaluation criteria 79
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 78
Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt 78
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma 78
Dynamic conformal arc therapy: transmitted signal in vivo dosimetry 78
In reply to Zilli and Miralbell 77
Thymoma and thymic carcinomas 77
Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting 76
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 76
Ulcerated breast cancer with single brain metastasis: a combined surgical approach. Clinical presentation at one year follow up - A case report 76
How has prostate cancer radiotherapy changed in Italy between 2004 and 2011? An analysis of the national Patterns Of Practice (POP) database by the uro-oncology study group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 76
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 75
Pacific trial: a new ocean or an abnormal wave? 75
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer 75
Prevention of radiotherapy-induced emesis 75
Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery 75
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 74
Tumor epithelial tumors: do we expect a brighter or a grey future? 74
COVID-19 and radiation induced pneumonitis: overlapping clinical features of different diseases 74
In reply to Fiorino et al.: the central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy 74
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 73
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study. 72
Comment on "Post-operative radiotherapy in non small cell lung cancer: update of individual patient data" [Lung Cancer 2005;47(1):81-83] 72
Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery 71
Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda 71
Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma 71
SBRT: A viable option for treating adrenal gland metastases 71
Early detection of cancer: lessons from lung cancer CT screening 71
Surgical de-escalation for re-excision in patients with a margin less than 2 mm and a diagnosis of DCIS 70
Prevention of delayed emesis induced by moderately emetogenic chemotherapy in patients with acute emesis: a pilot study with ACTH-Depot plus tropisetron 70
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 69
The first survey on defensive medicine in radiation oncology 68
Once Daily Accelerated Partial Breast Irradiation: Preliminary Results with Helical Tomotherapy® 68
Estimation of patient setup uncertainty using BrainLAB Exatrac X-Ray 6D system in image-guided radiotherapy 68
In Reply to Sharma and Izzuddeen 68
Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON? 67
nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives 67
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study. 67
Totale 9.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.100 63 164 88 38 23 132 68 47 49 48 59 321
2022/2023796 121 22 23 9 40 257 180 45 48 1 26 24
2023/2024330 67 30 24 10 21 53 19 10 15 10 35 36
2024/20253.385 31 628 319 191 53 215 245 116 271 414 408 494
2025/20264.476 229 304 511 391 281 139 517 536 669 386 300 213
2026/202721 21 0 0 0 0 0 0 0 0 0 0 0
Totale 12.684